Vaccine against covid-19: Municipality of BH closes agreement with Butantan to guarantee Coronavac – Rádio Itatiaia



[ad_1]

Photo: Disclosure / Instituto Butantan
Press Release / Instituto Butantan

The City Council of Belo Horizonte (PBH) reported this Wednesday morning (9) that it closed an agreement with the Butantan Institute, in São Paulo, to guarantee doses of the Coronavac vaccine against covid-19 from the Chinese company Sinovac, produced in São Paulo government society.

Belo Horizonte also already has, in partnership with the Federal University of Minas Gerais (UMFG), three super freezers available to store the Pfizer vaccine, if needed.

“The Municipality of Belo Horizonte reaffirms its expectation of being able to count on the National Immunization Program, coordinated by the Ministry of Health, regardless of which vaccine is approved. However, if vaccines from Butantan or Pfizer are first available, the Municipality has alliances to begin immunizing groups at risk as soon as possible, ”he says in a note.

Vaccination will obey priority criteria determined by the Municipal Health Secretariat and more details will be communicated in due course ”, he completes.

Coronavac

The São Paulo government expects to start the vaccination plan in the state on January 25. Initially, in the first phase, the immunizer would be applied to the elderly, health professionals. According to João Doria (PSDB), 4 million doses of the vaccine will be available for other states.

The application is subject to the presentation of the results of the effectiveness of the vaccine, which has not yet been produced, and the subsequent registration of the product by the National Health Surveillance Agency (Anvisa). Butantan promises to publish efficacy data before December 15.

Last week, the Ministry of Health released a preliminary vaccination plan against covid with the start of vaccination scheduled for March 2021. For now, the paste has guaranteed the supply of 100 million doses of the immunizer produced by AstraZeneca and the University of Oxford. and another 42 million from Covax facilities, an initiative of the World Health Organization (WHO).



[ad_2]